Quick Takeaways
- Cameron Turtle has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $31,580,518.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Cameron Turtle
- Location
- Waltham, MA
- Summary
- The estimated net worth of Cameron Turtle is at least $31,580,518 dollars as of 03 Apr 2026. Cameron Turtle is the Chief Executive Officer, Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $31.33M. Cameron Turtle is the Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $253.7K.
- Signature
- /s/ Heidy King-Jones, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Cameron Turtle and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Spyre Therapeutics, Inc. ($31,326,796).
- Past-year value change for that position: -$3,810,091.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Cameron Turtle
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | Chief Executive Officer, Director | $31,326,796 | -$3,810,091 | -11% | 01 Apr 2026 |
| ORKA | Oruka Therapeutics, Inc. | Director | $253,722 | 02 Jun 2025 | ||
| GLTO | Damora Therapeutics, Inc. | Director | 23 Mar 2026 |
Insider Transactions Reported by Cameron Turtle:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.